Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Waleed K. Al Hamoudi"'
Autor:
Saleh A. Alqahtani, Abdulrahman A. Aljumah, Almoutaz Hashim, Thamer H. Alenazi, Mohammed AlJawad, Waleed K. Al Hamoudi, Mohammed Y. Alghamdi
Publikováno v:
Annals of Saudi Medicine, Vol 40, Iss 4, Pp 273-280 (2020)
In December 2019, a novel coronavirus was identified in patients in Wuhan, China. The virus, subsequently named severe acute respiratory syndrome coronavirus-2, spread worldwide and the disease (coronavirus disease 2019 or COVID-19) was declared a gl
Externí odkaz:
https://doaj.org/article/a029c0de76a844e2aee535c2c0a3779c
Autor:
Saleh A. Alqahtani, Faisal Abaalkhail, Saad Alghamdi, Khalid Bzeizi, Waleed K. Al-Hamoudi, James M. Paik, Linda Henry, Bandar Al-Judaibi, Faisal M. Sanai, Zobair M. Younossi
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 30, Iss 5, Pp 310-318 (2024)
Background: Globally, viral hepatitis is decreasing, but nonalcoholic fatty liver disease (NAFLD), now metabolic dysfunction-associated steatotic liver disease (MASLD), is increasing. We assessed the burden and trends of MASLD and viral hepatitis in
Externí odkaz:
https://doaj.org/article/1ad1b14b02c94d22b45628ef2d35674f
Autor:
Saleh A. Alqahtani, Khalid Alswat, Mohamed Mawardi, Faisal M. Sanai, Faisal Abaakhail, Saad Alghamdi, Waleed K. Al-Hamoudi, Fatema Nader, Maria Stepanova, Zobair M. Younossi
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 30, Iss 5, Pp 335-341 (2024)
Background: A recent name change of nonalcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated fatty liver disease (MAFLD) to metabolic dysfunction-associated steatotic liver disease was primarily driven by potential stigma associat
Externí odkaz:
https://doaj.org/article/828bc2bf207f48429acd48f959b18d93
Autor:
Hala Joharji, Delal Alkortas, Aziza Ajlan, Mohamed Ahmed, Hamad Al‐Ashgar, Mohammed Al‐Quaiz, Dieter Broering, Mohammed Al‐Sebayel, Hussien Elsiesy, Faisal A. Alkhail, Waleed K. Al‐Hamoudi, Edward De Vol, Epi Amirah Almuhayshir, Ahmed Al‐Jedai
Publikováno v:
Health Science Reports, Vol 6, Iss 1, Pp n/a-n/a (2023)
Abstract Background and Aim Management of genotype 4 hepatitis C virus (HCV) has shifted to interferon‐free regimens with a high sustained virological response (SVR‐12), especially with NS5B/NS5A inhibitor combinations such as sofosbuvir and ledi
Externí odkaz:
https://doaj.org/article/f34ff6d71d564f559bcceae51a3db80b
Autor:
Saleh A. Alqahtani, Dieter C. Broering, Saad A. Alghamdi, Khalid I. Bzeizi, Noara Alhusseini, Saleh I. Alabbad, Ali Albenmousa, Nasreen Alfaris, Faisal Abaalkhail, Waleed K. Al-hamoudi
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Several trend analyses on liver transplantation (LT) indications have been published in the U.S. and in other countries, but there are limited data on LT indication trends in Saudi Arabia (SA), especially since the availability of
Externí odkaz:
https://doaj.org/article/4ff09a5d27bc410ab9292c1042cb481b
Autor:
Faisal A Abaalkhail, Waleed K Al-Hamoudi, Abdullah Khathlan, Saad Alghamdi, Mohammed Alghamdi, Saleh A Alqahtani, Faisal M Sanai
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 27, Iss 3, Pp 115-126 (2021)
Infection with hepatitis B virus (HBV) remains an important public health problem with a high burden worldwide. The Saudi Association for the Study of Liver diseases and Transplantation formed a working group to develop HBV practice guidelines in Sau
Externí odkaz:
https://doaj.org/article/9c98550ce3a44e66ac9fff0899489cef
Autor:
Saleh A Alqahtani, Mazin Barry, Ziad Memish, Almoutaz Hashim, Mona A Alfares, Saad A Alghamdi, Waleed K Al-Hamoudi, Bandar Al-Judaibi, Waleed Alhazzani, Jaffar A Al-Tawfiq, Faisal Abaalkhail
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 27, Iss 4, Pp 201-207 (2021)
Patients with chronic liver disease (CLD) and liver transplant recipients are at increased risk of morbidity and mortality from coronavirus disease 2019 (COVID-19). Although several studies demonstrated the safety and efficacy of COVID-19 vaccines in
Externí odkaz:
https://doaj.org/article/ebc1e618e80a4808821514348222c918
Publikováno v:
Case Reports in Medicine, Vol 2020 (2020)
Glycogen hepatopathy (GH) is a rare complication of type 1 diabetes mellitus that leads to an abnormal accumulation of glycogen in the hepatocytes. The exact mechanism of GH remains unknown, but fluctuations in blood glucose and insulin levels play i
Externí odkaz:
https://doaj.org/article/ef278e384c424fc598f55cf83c037a79
Autor:
Homie A. Razavi, Maria Buti, Norah A. Terrault, Stefan Zeuzem, Cihan Yurdaydin, Junko Tanaka, Alessio Aghemo, Ulus S. Akarca, Nasser M. Al Masri, Abduljaleel M. Alalwan, Soo Aleman, Abdullah S. Alghamdi, Saad Alghamdi, Waleed K. Al-Hamoudi, Abdulrahman A. Aljumah, Ibrahim H. Altraif, Tarik Asselah, Ziv Ben-Ari, Thomas Berg, Mia J. Biondi, Sarah Blach, Wornei S.M. Braga, Carlos E. Brandão-Mello, Maurizia R. Brunetto, Joaquin Cabezas, Hugo Cheinquer, Pei-Jer Chen, Myeong-Eun Cheon, Wan-Long Chuang, Carla S. Coffin, Nicola Coppola, Antonio Craxi, Javier Crespo, Victor De Ledinghen, Ann-Sofi Duberg, Ohad Etzion, Maria Lucia G. Ferraz, Paulo R.A. Ferreira, Xavier Forns, Graham R. Foster, Giovanni B. Gaeta, Ivane Gamkrelidze, Javier García-Samaniego, Liliana S. Gheorghe, Pierre M. Gholam, Robert G. Gish, Jeffrey Glenn, Julian Hercun, Yao-Chun Hsu, Ching-Chih Hu, Jee-Fu Huang, Naveed Janjua, Jidong Jia, Martin Kåberg, Kelly D.E. Kaita, Habiba Kamal, Jia-Horng Kao, Loreta A. Kondili, Martin Lagging, Pablo Lázaro, Jeffrey V. Lazarus, Mei-Hsuan Lee, Young-Suk Lim, Paul J. Marotta, Maria-Cristina Navas, Marcelo C.M. Naveira, Mauricio Orrego, Carla Osiowy, Calvin Q. Pan, Mário G. Pessoa, Giovanni Raimondo, Alnoor Ramji, Devin M. Razavi-Shearer, Kathryn Razavi-Shearer, Cielo Y. Ríos-Hincapié, Manuel Rodríguez, William M.C. Rosenberg, Dominique M. Roulot, Stephen D. Ryder, Rifaat Safadi, Faisal M. Sanai, Teresa A. Santantonio, Christoph Sarrazin, Daniel Shouval, Frank Tacke, Tammo L. Tergast, Juan Miguel Villalobos-Salcedo, Alexis S. Voeller, Hwai-I Yang, Ming-Lung Yu, Eli Zuckerman
Publikováno v:
Journal of Hepatology.
Autor:
Ahmed A. Al-Qahtani, Mashael R. Al-Anazi, Fahad A. Al-Zoghaibi, Ayman A. Abdo, Faisal M. Sanai, Waleed K. Al-Hamoudi, Khalid A. Alswat, Hamad I. Al-Ashgar, Mohammed Q. Khan, Ali Albenmousa, Hanif Khalak, Mohammed N. Al-Ahdal
Publikováno v:
Annals of Hepatology, Vol 15, Iss 6, Pp 824-833 (2016)
Background The protein encoded by PARK2 gene is a component of the ubiquitin-proteasome system that mediates targeting of proteins for the degradation pathway. Genetic variations at PARK2 gene were linked to various diseases including leprosy, typhoi
Externí odkaz:
https://doaj.org/article/bea38431ebaa400492a301587628e1df